No Picture
News

Biogen and Ionis report positive topline clinical data on investigational Alzheimer’s disease treatment at AAIC

CAMBRIDGE, Mass. and CARLSBAD, Calif.: CAMBRIDGE, Mass. and CARLSBAD, Calif., July 26, 2021 /PRNewswire/ — Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that topline data from a Phase 1b placebo-controlled, multiple ascending dose clinical study showed that BIIB080/IONIS-MAPTRx met its primary objective of safety and… Click here to view original post… […]

No Picture
News

Biomarker could help diagnosis schizophrenia at an early age

Research could lead to blood-based diagnostic test Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia. The activity of the protein, which is found in both the brain and blood, affects neural connections in… Click here to view original post… […]

No Picture
News

Chinese researcher — and former ‘fugitive’ — returns home after DOJ moves to drop a spate of cases

A year ago, the Trump administration’s crackdown on academic and espionage reached a fever pitch as the US abruptly ordered China to shut down its Houston consulate and, on the same day, announced it had charged four visiting Chinese researchers for concealing their ties to the Chinese military in visa… Click here to view original post… […]

No Picture
News

Poseida Therapeutics Appoints Cynthia Collins to Board of Directors

SAN DIEGO: SAN DIEGO, July 26, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nadsaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced the appointment of biotechnology industry veteran Cynthia Collins to its Board of Directors,… Click here to view original post… […]

No Picture
News

OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference

PENNINGTON, N.J. and SAN DIEGO: PENNINGTON, N.J. and SAN DIEGO, July 26, 2021 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D., will participate in a fireside… Click here to view original post… […]

No Picture
News

Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

SAN DIEGO, July 23, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and Lee’s Pharmaceutical Holdings Limited (HKEX: 950, “Lee’s Pharm”) announced today that, on July 15, 2021, China Oncology Focus Limited (“COF”), a subsidiary of Lee’s Pharm, has enrolled the first patient in China in the… Click here to view original post… […]

No Picture
News

‘Feel Good’ Brain Messenger Can Be Willfully Controlled, New Study Reveals

UC San Diego researchers and their colleagues have discovered that spontaneous impulses of dopamine, the neurological messenger known as the brain’s “feel good” chemical, occur in the brain of mice. The study found that mice can willfully manipulate these random dopamine pulses for reward. Click here to view original post… […]

No Picture
News

Jim Wilson startup Passage Bio plugs in CFO, CMO; Tillman Gerngross nabs a COO familiar with Covid-19 fight at Pfizer as Adagio files for IPO

Simona King ? Back in May, Passage Bio CFO Richard Morris and CMO Gary Romano left within days of each other, but this week the gene therapy player has found their replacements, along with a chief commercial officer. Simona King, a… Click here to view original post… […]

No Picture
News

Soft Skin Patch Could Provide Early Warning for Strokes, Heart Attacks

UC San Diego engineers developed a soft, stretchy ultrasound patch that can be worn on the skin to monitor blood flow through vessels deep inside the body. Such a device can make it easier to detect cardiovascular problems, like blockages in the arteries that could lead… Click here to view original post… […]

No Picture
News

Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation

SAN DIEGO: SAN DIEGO, July 21, 2021 /PRNewswire/ — Paramita Therapeutics, Inc. (Paramita) has been awarded a National Science Foundation Small Business Innovation Research grant for $255,990 to conduct research and development work on a novel dual-function therapeutic/vaccine product, designated as TheraVax™. TheraVax not only can block entry of SARS-CoV-2… Click here to view original post… […]

No Picture
News

Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced that it will host a virtual… Click here to view original post… […]

No Picture
News

Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences’ CAReS Study on July 28, 2021

LA JOLLA, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that Ladenburg Thalmann & Co…. Click here to view original post… […]

No Picture
News

Sorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that COVID-19 patients have been dosed in its Phase 2 efficacy trial. Approximately 350 outpatients with COVID-19 who are asymptomatic or have mild symptoms will be enrolled in this large double-blind, randomized clinical… Click here to view original post… […]

No Picture
News

Sorrento Announces That Its Subsidiary Levena and Its Partner Escugen Have Received Clearance to Begin Clinical Trials With Anti-TROP-2 Antibody Drug Conjugate For Multiple Solid Tumors

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its partner Escugen Biotechnology Co, Ltd. (“Escugen”) and Sorrento’s subsidiary Levena (Suzhou) Biopharma Co., Ltd. (“Levena”) have received an approval letter from the Center for Drug Evaluation (CDE) of the National Medical Products Administration… Click here to view original post… […]

No Picture
News

Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021

SAN DIEGO: SAN DIEGO, July 21, 2021 /PRNewswire/ — Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on… Click here to view original post… […]